TNFSF11 and rheumatoid arthritis: Our study has also demonstrated that TNFαI therapy modulates the RANKL/OPG pathway, a potential mechanism that could explain the improvement of the PINP/CTX-I ratio in RA patients follow treatment with anti-TNF-α inhibitors.